Karyopharm Therapeutics (KPTI) Files $200M Mixed Securities Shelf

November 8, 2016 8:56 AM EST

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Karyopharm Therapeutics (Nasdaq: KPTI) filed a registration with the U.S. SEC to sell up to $200 million of mixed securities.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Equity Offerings

Add Your Comment